arrow
K

Kusha Mohammadi

Regeneron
H指数:10
被引数:1,082

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)

使用作用机制不同的FXI/FXIa抗体amrecibart(REGN9933A2)和cenvacibart(REGN7508Cat)进行抗凝

Blood
IF23.1
2026-06-150
OAAI
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials

REGN9933A2和REGN7508Cat预防术后静脉血栓栓塞症(ROXI-VTE-I和ROXI-VTE-II)的疗效与安全性:两项随机、开放标签、Ⅱ期临床试验

2025-11-080
PRE
The Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results from the ODYSSEY OUTCOMES Trial

PCSK9抑制剂Alirocumab在疑似家族性高胆固醇血症或III型高脂蛋白血症患者中的疗效:ODYSSEY OUTCOMES试验结果

2024-11-120
PRE
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
2024-11-060
PRE
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
2024-08-311
OAAI
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Garetosmab治疗进行性骨化性纤维发育不良: 一项随机、双盲、安慰剂对照2期试验

2023-09-2817
OAAI
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Science
IF45.8
2020-01-010
OAAI